-
321
Unleashing the potential of extracellular vesicles for ulcerative colitis and Crohn's disease therapy
Published 2025-03-01“…Current therapies focus on reducing inflammation but often prove inadequate, leading to a substantial need for novel approaches. Cell therapy looks promising, especially using mesenchymal stromal cells (MSCs) and their secretome, including extracellular vesicles (EVs). …”
Get full text
Article -
322
Human Urine-Derived Stem Cells: Potential for Cell-Based Therapy of Cartilage Defects
Published 2018-01-01“…Stem cell therapy is considered an optimistic approach to replace current treatments for cartilage defects. …”
Get full text
Article -
323
Stromal Vascular Fraction and Amniotic Epithelial Cells: Preclinical and Clinical Relevance in Musculoskeletal Regenerative Medicine
Published 2021-01-01“…Musculoskeletal regenerative medicine is mainly based on the use of cell therapy to heal damaged tissues such as bone, cartilage, and tendons. …”
Get full text
Article -
324
Advances in regenerative medicine-based approaches for skin regeneration and rejuvenation
Published 2025-02-01“…This review examines core technologies including stem cell therapy, bioengineered skin substitutes, platelet-rich plasma (PRP), exosome-based therapies, and gene editing techniques like CRISPR. …”
Get full text
Article -
325
Engineering extracellular vesicles for ROS scavenging and tissue regeneration
Published 2024-06-01“…Abstract Stem cell therapy holds promise for tissue regeneration, yet significant challenges persist. …”
Get full text
Article -
326
ErbB- and MUC1-targeted CAR-T cell immunotherapy of oral squamous cell carcinoma
Published 2023-03-01“…Chimeric antigen receptor T (CAR-T) cell therapy has shown great success in treating B cell malignancies; however, there are many challenges that limit their therapeutic efficacy in solid tumours. …”
Get full text
Article -
327
Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations
Published 2018-01-01“…Immune tolerance and suppression in tumor microenvironments are the theoretical basis of immunotherapy. Adoptive cell therapy functions by stimulating and cultivating autologous lymphocytes ex vivo and then reinfusing them into the patient to kill cancer cells. …”
Get full text
Article -
328
Nonviral Gene Delivery of Growth and Differentiation Factor 5 to Human Mesenchymal Stem Cells Injected into a 3D Bovine Intervertebral Disc Organ Culture System
Published 2013-01-01“…Intervertebral disc (IVD) cell therapy with unconditioned 2D expanded mesenchymal stem cells (MSC) is a promising concept yet challenging to realize. …”
Get full text
Article -
329
Dual-targeting CAR T cells for B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma
Published 2025-02-01“…Abstract: Relapse after CD19-directed chimeric antigen receptor (CAR) T-cell therapy remains a major challenge in B-cell acute lymphoblastic leukemia (ALL) and B-cell non-Hodgkin lymphoma (B-NHL). …”
Get full text
Article -
330
Potensi Eugenol Fraksi Etil Asetat Bunga Cengkeh terhadap Proliferasi Kanker Serviks (HeLa Cell Line)
Published 2024-09-01“…<strong>Conclusion:</strong> Based on its potential, clove flower can be a candidate for cervical cancer cell therapy (HeLa Cell Line) in the future.</p><p><strong>Keywords</strong>: anti-cervical cancer, cervical cancer, cell proliferation, MTT assay, scratch assay </p>…”
Get full text
Article -
331
Administration of Melatonin in Diabetic Retinopathy Is Effective and Improves the Efficacy of Mesenchymal Stem Cell Treatment
Published 2022-01-01“…Stem cell transplantation is a promising therapeutic technique for the treatment of a variety of diseases; nevertheless, stem cell therapy may not always work as well as it could. …”
Get full text
Article -
332
Exploring the role and mechanisms of MAGEA4 in tumorigenesis, regulation, and immunotherapy
Published 2025-02-01“…MAGEA4-based TCR-T cell therapy and cancer vaccines show clinical potential. …”
Get full text
Article -
333
-
334
Stem Cell-Based Therapeutic Approaches to Restore Sensorineural Hearing Loss in Mammals
Published 2020-01-01“…Therefore, much attention has been paid on developing regenerative therapies to regenerate/replace the lost hair cells to treat the damaged cochlear sensory epithelium. The stem cell therapy is a promising approach to develop the functional hair cells and neuronal cells from endogenous and exogenous stem cell pool to recover hearing loss. …”
Get full text
Article -
335
Enhancing Mesenchymal Stromal Cell Immunomodulation for Treating Conditions Influenced by the Immune System
Published 2019-01-01“…Mesenchymal stromal cells (MSCs), formerly known as mesenchymal stem cells, are nonhematopoietic multipotent cells and are emerging worldwide as the most clinically used and promising source for allogeneic cell therapy. MSCs, initially obtained from bone marrow, can be derived from several other tissues, such as adipose tissue, placenta, and umbilical cord. …”
Get full text
Article -
336
The effect of Klotho protein complexed with nanomaterials on bone mesenchymal stem cell performance in the treatment of diabetic ischaemic ulcer
Published 2022-12-01“…The most important aspects of stem cell therapy are improving the microenvironment, cell homing and continuous factor stimulation. …”
Get full text
Article -
337
CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma
Published 2025-02-01“…IntroductionCAR-T cell therapy, though successful in hematologic malignancies, faces challenges in solid tumors due to limitations of autologous T cells. …”
Get full text
Article -
338
Challenges and Innovations in Alveolar Bone Regeneration: A Narrative Review on Materials, Techniques, Clinical Outcomes, and Future Directions
Published 2024-12-01“…It examines traditional techniques like guided bone regeneration and bone grafting, alongside newer methods such as stem cell therapy, gene therapy, and 3D bioprinting. Each approach is considered for its strengths in supporting bone growth and integration, especially in cases where complex bone defects make regeneration difficult. …”
Get full text
Article -
339
Polyclonal Recipient nTregs Are Superior to Donor or Third-Party Tregs in the Induction of Transplantation Tolerance
Published 2015-01-01“…We have previously reported successful induction of chimerism and tolerance using cell therapy with recipient T regulatory cells (Tregs) to avoid cytotoxic recipient treatment. …”
Get full text
Article -
340
Research Progress of Fuzheng Jiedu Huayu Method in Reducing Toxicity and Enhancing Efficacy of Immunotherapy
Published 2025-01-01“…Immunotherapy, including immune checkpoint inhibitors, tumor vaccine therapy, oncolytic virotherapy, and adoptive cell therapy, has made remarkably breakthroughs in the field of oncology. …”
Get full text
Article